<?xml version="1.0" encoding="UTF-8"?>
<urlset
  xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.weightlossrankings.org/research/new-york-medicaid-nyrx-glp1-coverage-pa-pathway-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-10T00:00:00.000Z</news:publication_date>
      <news:title>New York Medicaid (NYRx) GLP-1 Coverage (2026): Triple-Anchored Weight-Loss Exclusion + the Wegovy MACE Pathway</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/california-medi-cal-glp1-coverage-pa-pathway-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>California Medi-Cal GLP-1 Coverage (2026): The State Reversal That Removed Wegovy + Zepbound for Weight Loss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/texas-medicaid-glp1-coverage-pa-pathway-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Texas Medicaid GLP-1 Coverage (2026): What&apos;s Covered, STAR+PLUS PA Pathway, and How to Appeal a Denial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-alternatives-t2d-specifically</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro Alternatives (2026): T2D-Approved GLP-1s, Tirzepatide Cousins (Zepbound), and Off-Label vs On-Label Decisions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/wegovy-alternatives-weight-management-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Wegovy Alternatives (2026): Zepbound, Foundayo, Saxenda &amp; Cheaper Compounded Semaglutide Options</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/zepbound-alternatives-2026-caremark-displaced</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Zepbound Alternatives (2026): Wegovy, Foundayo, Compounded Tirzepatide &amp; The Caremark Formulary Reality</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/saxenda-liraglutide-weight-loss-evidence-generic-update</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Saxenda (Liraglutide) for Weight Loss: FDA Label, SCALE Trial Evidence, and the New Teva Generic (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mexican-diet-pills-safety-evidence-fda-warning</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Mexican Diet Pills: What&apos;s Actually Sold, FDA Warnings, and Why You Should Avoid Them (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/gip-receptor-medical-abbreviation-explained</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>What is GIP? GIP Receptor Explained (And Why Mounjaro/Zepbound Activate It Alongside GLP-1)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/best-oral-peptides-weight-loss-evidence-vs-hype</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Best Oral Peptides for Weight Loss (2026): What the Evidence Actually Shows vs the Hype</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/tirzepatide-online-pharmacy-legitimacy-verification-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Buying Tirzepatide Online: How to Verify Pharmacy Legitimacy (LegitScript, NABP, FDA Warning Letters)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/lomaira-phentermine-8mg-average-weight-loss-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Lomaira (Phentermine 8 mg): Average Weight Loss, How It Differs From Adipex-P 37.5 mg, and When TID Dosing Wins (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/newest-glp1-2026-recent-approvals-launches</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Newest GLP-1 Drugs (2026): Foundayo, Recently Approved &amp; Pipeline Launches in Order</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/rybelsus-alternatives-oral-semaglutide-not-working</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Rybelsus Alternatives: When Oral Semaglutide Isn&apos;t Working — Switching to Foundayo, Wegovy, or Compounded (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/how-to-get-phentermine-prescription-online-fda-approved</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>How to Get Phentermine Online: FDA-Approved Telehealth Pathways for Phentermine, Adipex-P, Lomaira &amp; Qsymia (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/wegovy-zepbound-switch-dose-equivalence-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Switching Wegovy to Zepbound (or Zepbound to Wegovy): Dose-Equivalence, Insurance Implications &amp; Side-Effect Reset (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/is-wegovy-ozempic-zepbound-same-as-disambiguation-faq-hub</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Is Wegovy the Same as Ozempic? Is Zepbound the Same as Mounjaro? Complete GLP-1 Disambiguation FAQ (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-medication-list-2026-full-reference</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Medication List 2026: Every FDA-Approved &amp; Investigational GLP-1 Drug in One Reference</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-oral-pills-rybelsus-foundayo-wegovy-oral-comparison</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Pills (2026): Rybelsus, Foundayo &amp; Wegovy Oral — Side-by-Side Comparison of Every Oral GLP-1</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-generic-timeline-when-will-each-go-generic</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Generics (2026): When Will Wegovy, Ozempic, Mounjaro &amp; Zepbound Go Generic? Patent Cliff Tracker</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/trulicity-dulaglutide-weight-loss-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Trulicity (Dulaglutide) for Weight Loss: FDA Label, Evidence, and How It Compares to Wegovy/Ozempic (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/birth-control-weight-loss-evidence-review</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>What Birth Control Causes Weight Loss? An Evidence Review of Hormonal Contraception and Body Weight (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/foundayo-zepbound-switch-dose-equivalence-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Switching Between Foundayo (Orforglipron) and Zepbound (Tirzepatide): What the FDA Labels Say About Dose Equivalence (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/retatrutide-approval-access-timeline-2026-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Retatrutide Approval &amp; Access Timeline 2026-27: TRIUMPH Readouts, NDA Path, and Why You Cannot Legally Compound It</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-pcos-polycystic-ovary-syndrome-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1s for PCOS (Polycystic Ovary Syndrome) Evidence &amp; Insurance Coverage 2026: Off-Label Use, Trial Data &amp; How to Get Approved</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/foundayo-orforglipron-week-by-week-titration-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Foundayo (Orforglipron) Week-by-Week (2026): Days 1-90 Titration Schedule, What to Expect &amp; Common Questions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-body-dysmorphia-disclosure-post-loss-grief-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Body Dysmorphia, Disclosure &amp; Post-Loss Grief on GLP-1 (2026): The Psychosocial Side of Rapid Weight Loss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-mental-health-anhedonia-emotional-blunting-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1s &amp; Mental Health (2026): What the FDA&apos;s January 2026 Suicidality Warning Removal Means for Mood, Anhedonia &amp; Depression</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/zepbound-vs-wegovy-cost-comparison</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Zepbound vs Wegovy Cost (2026): Self-Pay, Insurance Copay, Caremark Formulary &amp; Total-Cost Comparison</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/life-after-glp1-maintenance-decision-hub</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Life After GLP-1: Maintenance Dosing, Microdosing, Tapering &amp; What Happens When You Stop (2026 Decision Hub)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-insurance-dropped-coverage-appeal-playbook</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Insurance Dropped Your GLP-1? The Complete Appeal Playbook for CVS Caremark, Cigna, Aetna, UHC (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/qsymia-phentermine-topiramate-weight-loss-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Qsymia (Phentermine + Topiramate ER) for Weight Loss: FDA Label, CONQUER Evidence &amp; How It Compares to GLP-1s (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/best-appetite-suppressant-fda-approved-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Best Appetite Suppressant 2026: FDA-Approved Pills, Injections &amp; Drugs Compared</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/ozempic-alternatives-complete-guide-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Ozempic Alternatives (2026): FDA-Approved GLP-1s, Cheaper Semaglutide &amp; Non-GLP-1 Options</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/zepbound-generic-tirzepatide-biosimilar-timeline</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Zepbound Generic / Tirzepatide Biosimilar: When Will It Be Available? (2026 Status)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/zepbound-vs-wegovy-side-effects-comparison</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Zepbound vs Wegovy Side Effects: Head-to-Head Comparison from the FDA Labels (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/diabetes-vs-weight-loss-glp1-medication-disambiguation</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Diabetes Weight Loss Drug — Which Is Which? Untangling Ozempic, Mounjaro, Wegovy, Zepbound, Foundayo (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/wegovy-vs-mounjaro-different-molecules-decision-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Wegovy vs Mounjaro: Different Molecules, Different Indications — How to Choose (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/wegovy-goodrx-glp1-cash-pay-coupon-channel-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Wegovy GoodRx, NovoCare $299, Costco $349, Sam&apos;s Club: Every GLP-1 Cash-Pay Coupon &amp; Channel (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-vs-zepbound-complete-comparison</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro vs Zepbound: Same Drug, Different Brand Names — Complete Side-by-Side Comparison (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/bariatric-surgery-vs-glp1-decision-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Bariatric Surgery vs GLP-1 vs Combination: A Decision Guide With 13 Verified Trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/aetna-glp1-prior-authorization-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Aetna GLP-1 Prior Authorization Guide: Verbatim PA Criteria for Wegovy, Zepbound, Saxenda, Ozempic, and Mounjaro (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cigna-glp1-prior-authorization-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Cigna GLP-1 Prior Authorization Guide: Verbatim PA Criteria for Wegovy, Zepbound, Foundayo, Ozempic, and Mounjaro (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/aetna-glp1-autorizacion-previa-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Guía de autorización previa de Aetna para GLP-1: criterios textuales para Wegovy, Zepbound, Saxenda, Ozempic y Mounjaro (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cigna-glp1-autorizacion-previa-guia</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Guía de autorización previa de Cigna para GLP-1: criterios textuales para Wegovy, Zepbound, Foundayo, Ozempic y Mounjaro (2026)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/cirugia-bariatrica-vs-glp1-guia-decision</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Cirugía bariátrica vs GLP-1 vs combinación: guía de decisión con 13 ensayos verificados</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-zepbound-fda-prescribing-information-explained</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro vs Zepbound: FDA Prescribing Information Explained Side-by-Side</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-zepbound-informacion-prescripcion-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-09T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro vs Zepbound: La información de prescripción de la FDA explicada lado a lado</news:title>
    </news:news>
  </url>
</urlset>